NCT05106387Recruiting
An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
A Noninterventional Extension Study for Patients Treated in Study R5459-RT-1944 With Vonsetamig (BCMA x CD3 Bispecific Antibody) Who Receive a Kidney Transplant
Source: ClinicalTrials.gov · Last updated 25 Sept 2026
Brief summary (registry, in English)
The main purpose of this study is to continue to see how vonsetamig works in the body and to monitor the outcomes after kidney transplant for participants previously treated in the R5459-RT-1944 study (NCT05092347). No study drug will be given during this study.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 20 (estimated)
- First submitted
- 22 Oct 2021
- Start date
- 19 Oct 2023
- Primary completion date
- 14 Jun 2027
- Lead sponsor
- Regeneron Pharmaceuticals
- Diseases
- Chronic kidney disease
- NCT number
- NCT05106387
What you commit to
- Study type: Observational
- Planned participants: 20
- From 19 Oct 2023 to the primary completion date, 14 Jun 2027
- 9 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- 1.There are no exclusion criteria for this study.
- Note: Other protocol defined Inclusion/Exclusion criteria may apply
Who the study is looking for
- Received at least 1 dose of treatment with vonsetamig in study R5459-RT-1944 \[NCT05092347\].
- Received after acceptable crossmatching, a kidney transplant while enrolled in study R5459-RT-1944
- Willing and able to comply with clinic visits and study-related procedures
- Provide informed consent signed by study patient or legally acceptable representative
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (9)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| John Hopkins Hospital Coordinator of this site? Confirm its status | Baltimore | United States | Recruiting |
| Comprehensive Transplant Center Coordinator of this site? Confirm its status | Chicago | United States | Recruiting |
| Cedars-Sinai Medical Center Coordinator of this site? Confirm its status | Los Angeles | United States | Recruiting |
| University of Minnesota Coordinator of this site? Confirm its status | Minneapolis | United States | Recruiting |
| Yale University of Medicine Coordinator of this site? Confirm its status | New Haven | United States | Completed |
| New York University Langone Health Coordinator of this site? Confirm its status | New York | United States | Recruiting |
| University of California Irvine Coordinator of this site? Confirm its status | Orange | United States | Recruiting |
| Penn Transplant Institute Coordinator of this site? Confirm its status | Philadelphia | United States | Recruiting |
| Connie Frank Transplant Center at UCSF Coordinator of this site? Confirm its status | San Francisco | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.